U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. U.S. authorities for months have recommended that Americans starting their COVID-19 vaccinations use the Pfizer or Moderna shots instead.
In December, the Centers for Disease Control and Prevention recommended prioritizing Moderna and Pfizer shots over J&J's because of its safety issues. Previously, U.S. officials had treated all three vaccines similarly because they'd each been shown to offer strong protection. A J&J spokesman said in an emailed statement: "Data continue to support a favorable benefit-risk profile for the Johnson & Johnson COVID-19 vaccine in adults, when compared with no vaccine."
The clotting problems first came up last spring, with the J&J shot in the U.S. and with a similar vaccine made by AstraZeneca that is used in other countries. At that time, U.S. regulators decided the benefits of J&J’s one-and-done vaccine outweighed what was considered a very rare risk — as long as recipients were warned.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot riskThe Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
Baca lebih lajut »
FDA puts strict limits on Johnson & Johnson Covid-19 vaccineThe US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren't appropriate or accessible and those who opt for J&J because they wouldn't otherwise get vaccinated.
Baca lebih lajut »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Baca lebih lajut »
FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot riskU.S. regulators have strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Baca lebih lajut »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsBREAKING NEWS: U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Baca lebih lajut »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Baca lebih lajut »